Evaluation of long-read 16S rRNA next-generation sequencing for identification of bacterial isolates in a clinical diagnostic laboratory
Open Access
- 14 May 2025
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (5) , e0167024
Abstract
Sanger sequencing of the first ~500 bp of the 16S rRNA gene is frequently used to identify bacterial pathogens that have ambiguous biochemical profiles or proteomic mass spectra. When diversity does not occur within that region, genus-level and/or species-level identification may not be possible, and a longer sequence or alternative target may be required to distinguish between genera/species. In this study, we evaluated a clinically relevant end-to-end solution for long-read (~1,500 nt) 16S rRNA next-generation sequencing by Oxford Nanopore Technologies (ONT) compared to a ~500 nt Sanger sequencing approach for the identification of 153 bacterial clinical isolates. Sequencing data were analyzed using the IDNS software from SmartGene and its proprietary 16S Centroid reference database (Centroid database) SmartGene software and the Centroid database. The agreement of the two platforms on species- and genus-level identification was determined, and discrepancies were resolved by whole-genome sequencing. ONT had a higher taxonomic resolution at the genus level ( P < 0.01). When genus-level identification was achieved by both methods, concordance to the best matching genus was 100%. When species-level identification was achieved by both methods, concordance to the best matching species was 91%. The costs per test were ~$25.30 (when multiplexing 24 samples/run) and $74 for ONT and Sanger sequencing, respectively. The hands-on time spent performing sequencing was similar for both methods, but the turnaround time of ONT was significantly shorter than that of Sanger sequencing. IMPORTANCE: This study adds to existing literature by describing a validated end-to-end solution of 16S rRNA gene Oxford Nanopore sequencing for bacterial isolate identification, including sequencing run time evaluation, automated analysis (SmartGene 16S Identification App) and interpretation of results, that can be incorporated into clinical and public health laboratories with a simple and cost-effective workflow.Keywords
This publication has 36 references indexed in Scilit:
- Application of nanopore sequencing for accurate identification of bioaerosol-derived bacterial coloniesEnvironmental Science: Atmospheres, 2024
- Using nanopore sequencing to identify bacterial infection in joint replacements: a preliminary studyBriefings in Functional Genomics, 2024
- Implementation of full-length 16S nanopore sequencing for bacterial identification in a clinical diagnostic settingDiagnostic Microbiology and Infectious Disease, 2023
- Application of Nanopore Sequencing in the Diagnosis and Treatment of Pulmonary InfectionsMolecular Diagnosis & Therapy, 2023
- Nanopore 16S amplicon sequencing enables rapid detection of pathogen in knee periprosthetic joint infectionInternational Journal of Medical Microbiology, 2022
- Oxford Nanopore R10.4 long-read sequencing enables the generation of near-finished bacterial genomes from pure cultures and metagenomes without short-read or reference polishingNature Methods, 2022
- DNA assembly for nanopore data storage readoutNature Communications, 2019
- High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundariesNature Communications, 2018
- Retrieval of a million high-quality, full-length microbial 16S and 18S rRNA gene sequences without primer biasNature Biotechnology, 2018
- A portable system for rapid bacterial composition analysis using a nanopore-based sequencer and laptop computerScientific Reports, 2017